Latest Europe News

Clover Corporation has reported a robust first half for FY26, with revenue climbing 17% and margins expanding significantly, underpinning a confident revenue forecast for the full year.

Battery Age Minerals has validated its exploration model with maiden drilling results at Austria’s Bleiberg district, intersecting promising zinc-lead-germanium mineralisation. The company plans further targeted drilling to expand on these early successes.

Yugo Metals has received formal government approval for its 100%-owned Petrovo tenement in Bosnia and Herzegovina, opening the door to advance one of Europe’s most promising high-grade polymetallic systems. Exceptional grades of nickel, zinc, lead, antimony, gold, and silver have been confirmed, setting the stage for a new phase of exploration.

Advanced Energy Minerals is ramping up production capacity at its Quebec plant, leveraging patented low-cost technology and renewable energy to meet booming global demand for high purity alumina.

Little Green Pharma has terminated its planned sale and leaseback of its Western Australian production facility after failing to reach commercial terms, choosing to retain ownership without impacting operations.

EQ Resources Limited showcased its strategic position as a leading tungsten producer with strong growth ambitions amid a tightening global supply deficit. The company’s dual operations in Australia and Spain underpin its role in securing ethical tungsten supply chains for Western markets.

Viridis Mining and Minerals has raised AU$25 million through a heavily oversubscribed placement, bolstering its cash position to approximately AU$76 million as it advances the Colossus Rare Earth Project towards a Final Investment Decision in Q3 2026.

Xref Limited has launched strategic integrations with leading HR platforms Teamtailor and HiBob, aiming to accelerate its transition to a high-margin, API-driven revenue model and expand its global footprint.

Biotron Limited reveals that its lead antiviral candidate BIT-HBV001 shows promising activity against Hepatitis Delta Virus, expanding its potential impact beyond Hepatitis B. Meanwhile, the company completes integration of Sedarex and advances regulatory plans for its anaesthetic SedRx.

Vulcan Energy has obtained its inaugural lithium production licence for the Lionheart Project in Germany, marking a pivotal step as the project moves into funded construction. This licence supports Vulcan’s ambition to supply Europe with sustainable lithium for electric vehicle batteries, backed by renewable energy co-production.

dorsaVi has secured significant commercial and clinical milestones with new elite sports and European clinical partnerships, showcasing its advanced real-time AI sensor technology.

Evion Group is advancing the Stage 2 expansion of its expandable graphite facility in India to boost production capacity amid rising demand from Europe, the USA, and Asia. The upgrade aligns with the EU’s recognition of graphite as a critical mineral, positioning Evion as a key supplier in strategic sectors.